Skip to content
Financing

Proceeds from exercises of stock options and other stock issuances

GE HealthCare Technologies Proceeds from exercises of stock options and other stock issuances decreased by 16.7% to $10M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 50.0%, from $20M to $10M.

Analysis

StatementCash Flow Statement
SectionFinancing
First reportedQ1 2022
Last reportedQ1 2026Apr 29, 2026
Metric ID: financing_proceeds_from_issuance_of_shares_under_incenti_d15335

Historical Data

14 periods
 Q1 '22Q2 '22Q3 '22Q4 '22Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$0$0$0$0$3M$16M$8M$7M$2M$20M$1M$4M$12M$10M
QoQ Change+433.3%-50.0%-12.5%-71.4%+900.0%-95.0%+300.0%+200.0%-16.7%
YoY Change-33.3%+25.0%-87.5%-42.9%+500.0%-50.0%
Range$0$20M
Avg YoY Growth+51.9%
Median YoY Growth-38.1%

Proceeds from exercises of stock options and other stock issuances at Other Companies

Frequently Asked Questions

What is GE HealthCare Technologies's proceeds from exercises of stock options and other stock issuances?
GE HealthCare Technologies (GEHC) reported proceeds from exercises of stock options and other stock issuances of $10M in Q1 2026.
How has GE HealthCare Technologies's proceeds from exercises of stock options and other stock issuances changed year-over-year?
GE HealthCare Technologies's proceeds from exercises of stock options and other stock issuances decreased by 50.0% year-over-year, from $20M to $10M.